Table 4.

Lenalidomide treatment exposure (safety population)

	L (n = 13)	L + R (n = 11)	L + other (n = 34)	Overall (N = 58)
Lenalidomide treatment duration, weeks
Median	8.4	14.0	7.0	8.4
Range	0.4 to 30.0	0.9 to 37.9	1.1 to 77.9	0.4 to 77.9
Number of lenalidomide cycles
Median	2.0	2.0	1.0	2.0
Range	1.0 to 7.0	1.0 to 9.0	0.0 to 11.0	0.0 to 11.0
Duration of other therapy combined with lenalidomide, weeks
Median	NA	8.3	7.2	7.4
Range	NA	0.1 to 35.9	0.7 to 77.7	0.1 to 77.7

L lenalidomide, L + R lenalidomide plus rituximab, NA not applicable